An AHA science advisory based on recent evidence suggests that for resuscitated out-ot-hospital cardiac arrest patients, controlling temperature to less than 37.5° C is a "reasonable" approach.
The FDA says medical device manufacturer Abiomed has voluntarily recalled labeling that s short on safety information for one model in its line of circulatory-assist pumps.
BioXcel Therapeutics said on Monday it will cut more than half of its workforce, as the drugmaker shifts its focus towards developing its agitation treatment for use in at-home settings.